scholarly journals Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection

2020 ◽  
Author(s):  
Midas B. Mulder ◽  
Robert A. Man ◽  
Nassim Kamar ◽  
Gűlcan Durmaz ◽  
Joep Bruijne ◽  
...  
2020 ◽  
Vol 104 (2) ◽  
pp. 437-444 ◽  
Author(s):  
Yohei Owada ◽  
Yukio Oshiro ◽  
Yuki Inagaki ◽  
Hiroshi Harada ◽  
Nobuhiro Fujiyama ◽  
...  

2020 ◽  
Vol 73 ◽  
pp. S855-S856
Author(s):  
Midas Mulder ◽  
Robert De Man ◽  
Nassim Kamar ◽  
Gülcan Durmaz ◽  
Joep de Bruijne ◽  
...  

2012 ◽  
Vol 31 (4) ◽  
pp. S143
Author(s):  
H.Y. van der Weide ◽  
E.B. Haagsma ◽  
B.G.M. Niesters ◽  
A. Riezebos-Brilman ◽  
E.A.M. Verschuuren

2014 ◽  
Vol 370 (12) ◽  
pp. 1111-1120 ◽  
Author(s):  
Nassim Kamar ◽  
Jacques Izopet ◽  
Simona Tripon ◽  
Michael Bismuth ◽  
Sophie Hillaire ◽  
...  

2008 ◽  
Vol 14 (4) ◽  
pp. 547-553 ◽  
Author(s):  
Elizabeth B. Haagsma ◽  
Arie P. van den Berg ◽  
Robert J. Porte ◽  
Cornelis A. Benne ◽  
Harry Vennema ◽  
...  

2019 ◽  
Vol 6 (8) ◽  
Author(s):  
E M van Wezel ◽  
J de Bruijne ◽  
K Damman ◽  
M Bijmolen ◽  
A P van den Berg ◽  
...  

Abstract Ribavirin is effective for treating immunocompromised patients with chronic hepatitis E virus infection. However, ribavirin treatment is not always successful. We describe 3 solid organ transplant recipients treated with sofosbuvir and ribavirin after failing ribavirin monotherapy. Complete elimination of hepatitis E virus could not be achieved.


2014 ◽  
Vol 16 (2) ◽  
pp. 333-339 ◽  
Author(s):  
S. Pischke ◽  
M. Greer ◽  
S. Hardtke ◽  
B. Bremer ◽  
A. Gisa ◽  
...  

EBioMedicine ◽  
2015 ◽  
Vol 2 (11) ◽  
pp. 1607-1612 ◽  
Author(s):  
Yuki Inagaki ◽  
Yukio Oshiro ◽  
Tomohiro Tanaka ◽  
Tomoharu Yoshizumi ◽  
Hideaki Okajima ◽  
...  

2013 ◽  
Vol 32 (1) ◽  
pp. 78-85 ◽  
Author(s):  
Ludi Koning ◽  
Suzan D. Pas ◽  
Robert A. de Man ◽  
Aggie H.M.M. Balk ◽  
Robert J. de Knegt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document